{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:43:44Z","timestamp":1777416224652,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,19]],"date-time":"2014-07-19T00:00:00Z","timestamp":1405728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s11095-014-1447-7","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T21:45:15Z","timestamp":1405719915000},"page":"91-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Superoxide Dismutase Enzymosomes: Carrier Capacity Optimization, in Vivo Behaviour and Therapeutic Activity"],"prefix":"10.1007","volume":"32","author":[{"given":"M. Lu\u00edsa","family":"Corvo","sequence":"first","affiliation":[]},{"given":"H. Susana","family":"Marinho","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Marcelino","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Carlos A.","family":"Vale","sequence":"additional","affiliation":[]},{"given":"Cla\u00fadia R.","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Lu\u00edsa C.D.","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Laverman","sequence":"additional","affiliation":[]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[]},{"given":"M. B\u00e1rbara A.F.","family":"Martins","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,7,19]]},"reference":[{"issue":"6","key":"1447_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/jps.22054","volume":"99","author":"DS Pisal","year":"2010","unstructured":"Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci. 2010;99(6):2557\u201375.","journal-title":"J Pharm Sci"},{"key":"1447_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-012373947-6.00285-3","volume-title":"Encyclopaedia of stress","author":"H Sies","year":"2007","unstructured":"Sies H, Jones DP. Oxidative stress. In: Fink G, editor. Encyclopaedia of stress. London: Elsevier; 2007. p. 45\u20138."},{"issue":"3","key":"1447_CR3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.taap.2013.09.031","volume":"273","author":"S Saeidnia","year":"2013","unstructured":"Saeidnia S, Abdollahi M. Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicol Appl Pharmacol. 2013;273(3):442\u201355.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"1447_CR4","first-page":"17","volume":"54","author":"LS Cushing","year":"1973","unstructured":"Cushing LS, Decker WE, Santos FK, Schulte TL, Huber W. Orgotein therapy for inflammation in horses. Mod Vet Pract. 1973;54(7):17\u201321.","journal-title":"Mod Vet Pract"},{"issue":"3","key":"1447_CR5","first-page":"466","volume":"18","author":"H Marberger","year":"1975","unstructured":"Marberger H, Bartsch G, Huber W, Menander KB, Schulte TL. Orgotein: a new drug for the treatment of radiation cystitis. Curr Ther Res Clin Exp. 1975;18(3):466\u201375.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"2","key":"1447_CR6","first-page":"308","volume":"12","author":"W Huber","year":"1968","unstructured":"Huber W, Schulte TL, Carson S, Golddhame RE, Vogin EE. Some chemical and pharmacologic properties of a novel anti-inflammatory protein. Toxicol Appl Pharmacol. 1968;12(2):308.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"1447_CR7","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1007\/s11095-013-1113-5","volume":"30","author":"J Carillon","year":"2013","unstructured":"Carillon J, Rouanet JM, Cristol JP, Brion R. Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action. Pharmaceut Res. 2013;30(11):2718\u201328.","journal-title":"Pharmaceut Res"},{"issue":"2","key":"1447_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0005-2736(99)00081-4","volume":"1419","author":"ML Corvo","year":"1999","unstructured":"Corvo ML, Boerman OC, Oyen WJ, van Bloois L, Cruz MEM, Crommelin DJA, et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta. 1999;1419(2):325\u201334.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1447_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0005-2736(02)00457-1","volume":"1564","author":"ML Corvo","year":"2002","unstructured":"Corvo ML, Jorge JCS, van\u2019t Hof R, Cruz MEM, Crommelin DJA, Storm G. Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis. Biochim Biophys Acta. 2002;1564(1):227\u201336.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1447_CR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0169-409X(02)00029-7","volume":"54","author":"FM Veronese","year":"2002","unstructured":"Veronese FM, Caliceti P, Schiavon O, Sergi M. Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv Drug Deliv Rev. 2002;54(4):587\u2013606.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1447_CR11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2006.10.018","volume":"117","author":"MM Gaspar","year":"2007","unstructured":"Gaspar MM, Boerman OC, Laverman P, Corvo ML, Storm G, Cruz MEM. Enzymosomes with surface-exposed superoxide dismutase: in vivo behaviour and therapeutic activity in a model of adjuvant arthritis. J Control Release. 2007;117(2):186\u201395.","journal-title":"J Control Release"},{"issue":"2","key":"1447_CR12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jconrel.2004.12.008","volume":"103","author":"SID Sim\u00f5es","year":"2005","unstructured":"Sim\u00f5es SID, Delgado TC, Lopes RM, Jesus S, Ferreira AA, Morais JA, et al. Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in transfersomes. J Control Release. 2005;103(2):419\u201334.","journal-title":"J Control Release"},{"issue":"4","key":"1447_CR13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.eururo.2005.04.011","volume":"48","author":"CR Riedl","year":"2005","unstructured":"Riedl CR, Sternig P, Galle G, Langmann F, Vcelar B, Vorauer K, et al. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie\u2019s disease: a randomized placebo-controlled double-blind prospective clinical study. Eur Urol. 2005;48(4):656\u201361.","journal-title":"Eur Urol"},{"issue":"1","key":"1447_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(96)01473-3","volume":"43","author":"ML Corvo","year":"1997","unstructured":"Corvo ML, Martins MBF, Francisco AP, Morais JG, Cruz MEM. Liposomal formulations of Cu, Zn-superoxide dismutase: physico-chemical characterization and activity assessment in an inflammation model. J Control Release. 1997;43(1):1\u20138.","journal-title":"J Control Release"},{"issue":"5","key":"1447_CR15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1023\/A:1007577101964","volume":"17","author":"ML Corvo","year":"2000","unstructured":"Corvo ML, Boerman OC, Oyen WJ, Jorge JC, Cruz MEM, Crommelin DJA, et al. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model. Pharm Res. 2000;17(5):600\u20136.","journal-title":"Pharm Res"},{"issue":"2","key":"1447_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2736(02)00702-2","volume":"1609","author":"MM Gaspar","year":"2003","unstructured":"Gaspar MM, Martins MBF, Corvo ML, Cruz MEM. Design and characterization of enzymosomes with surface-exposed superoxide dismutase. Biochim Biophys Acta. 2003;1609(2):211\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"1447_CR17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0076-6879(05)91022-7","volume":"391","author":"MEM Cruz","year":"2005","unstructured":"Cruz MEM, Gaspar MM, Martins MBF, Corvo ML. Liposomal superoxide dismutases and their use in the treatment of experimental arthritis. Methods Enzymol. 2005;391:395\u2013413.","journal-title":"Methods Enzymol"},{"key":"1447_CR18","unstructured":"Vale C, Corvo ML, Martins LCD, Marques CR, Storm G, Cruz MEM, Martins MBF Construction of enzymosomes: optimization of coupling parameters. 2 NSTI-Nanotech 2006, 2006, 396\u2013397."},{"issue":"9","key":"1447_CR19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0300-9084(90)90050-Q","volume":"72","author":"MBF Martins","year":"1990","unstructured":"Martins MBF, Jorge JCS, Cruz MEM. Acylation of L-asparaginase with total retention of enzymatic activity. Biochimie. 1990;72(9):671\u20135.","journal-title":"Biochimie"},{"key":"1447_CR20","unstructured":"Cruz MEM, Jorge JCS, Martins MBF, Gaspar MM, Sim\u00f5es ACE, Perez-Soler R. Liposomal compsn. contg. L-Asparaginase - used for effective treatment of tumours, partic. human acute lymphoblastic leukaemia. Patent Number: EP485143-A1; 1992."},{"issue":"4","key":"1447_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1021\/bc9600269","volume":"7","author":"MBF Martins","year":"1996","unstructured":"Martins MBF, Goncalves APV, Cruz MEM. Biochemical characterization of an L-asparaginase bioconjugate. Bioconjug Chem. 1996;7(4):430\u20135.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"1447_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pola.22388","volume":"46","author":"R Solaro","year":"2008","unstructured":"Solaro R. Targeted delivery of proteins by nanosized carriers. J Polym Sci, Part A: Polym Chem. 2008;46(1):1\u201311.","journal-title":"J Polym Sci, Part A: Polym Chem"},{"issue":"3","key":"1447_CR23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0304-4165(92)90022-M","volume":"1117","author":"JLM Heeremans","year":"1992","unstructured":"Heeremans JLM, Kraaijenga JJ, Los P, Kluft C, Crommelin DJA. Development of a procedure for coupling the homing device Glu-plasminogen to liposomes. Biochim Biophys Acta. 1992;1117(3):258\u201364.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1447_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0005-2736(85)90430-4","volume":"814","author":"JTP Derksen","year":"1985","unstructured":"Derksen JTP, Scherphof GL. An improved method for the covalent coupling of proteins to liposomes. Biochim Biophys Acta. 1985;814(1):151\u20135.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1447_CR25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0003-9861(73)80023-2","volume":"155","author":"P Bohlen","year":"1973","unstructured":"Bohlen P, Stein S, Dairman W, Udenfriend S. Fluorimetric assay of proteins in the nanogram range. Arch Biochem Biophys. 1973;155(1):213\u201320.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"1447_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193(1):265\u201375.","journal-title":"J Biol Chem"},{"issue":"5","key":"1447_CR27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF02531316","volume":"5","author":"G Rouser","year":"1970","unstructured":"Rouser G, Fleischer S, Yamamoto A. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 1970;5(5):494\u20136.","journal-title":"Lipids"},{"issue":"10","key":"1447_CR28","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170\u20135.","journal-title":"J Biol Chem"},{"issue":"1","key":"1447_CR29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nano.2013.06.008","volume":"10","author":"MBF Martins","year":"2014","unstructured":"Martins MBF, Corvo ML, Marcelino P, Marinho HS, Feio G, Carvalho A. New long circulating magnetoliposomes as contrast agents for detection of ischemia-reperfusion injuries by MRI. Nanomedicine: NBM. 2014;10(1):207\u201314.","journal-title":"Nanomedicine: NBM"},{"issue":"2","key":"1447_CR30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0925-4439(96)00075-0","volume":"1360","author":"HS Marinho","year":"1997","unstructured":"Marinho HS, Baptista M, Pinto RE. Glutathione metabolism in hepatomous liver of rats treated with diethylnitrosamine. Biochim Biophys Acta. 1997;1360(2):157\u201368.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1447_CR31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/clinchem\/24.1.58","volume":"24","author":"HU Bergmeyer","year":"1978","unstructured":"Bergmeyer HU, Scheibe P, Wahlefeld AW. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem. 1978;24(1):58\u201373.","journal-title":"Clin Chem"},{"issue":"2","key":"1447_CR32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj1860591","volume":"186","author":"C Kirby","year":"1980","unstructured":"Kirby C, Clarke J, Gregoriadis G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J. 1980;186(2):591\u20138.","journal-title":"Biochem J"},{"issue":"5","key":"1447_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0163-7827(00)00013-8","volume":"39","author":"OC Boerman","year":"2000","unstructured":"Boerman OC, Laverman P, Oyen WJ, Corstens FH, Storm G. Radiolabeled liposomes for scintigraphic imaging. Prog Lipid Res. 2000;39(5):461\u201375.","journal-title":"Prog Lipid Res"},{"issue":"6","key":"1447_CR34","first-page":"901","volume":"38","author":"MH Kranenborg","year":"1997","unstructured":"Kranenborg MH, Oyen WJG, Corstens FHM, Oosterwijk E, vander Meer JWM, Boerman OC. Rapid imaging of experimental infection with technetium-99\u00a0m-DTPA after anti-DTPA monoclonal antibody priming. J Nucl Med. 1997;38(6):901\u20136.","journal-title":"J Nucl Med"},{"issue":"6","key":"1447_CR35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/ard.56.6.369","volume":"56","author":"OC Boerman","year":"1997","unstructured":"Boerman OC, Oyen WJG, Storm G, Corvo ML, van Bloois L, vander Meer JWM, et al. Tc-99\u00a0m labeled liposomes to image experimental arthritis. Ann Rheum Dis. 1997;56(6):369\u201373.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1447_CR36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.22117","volume":"16","author":"M Abu-Amara","year":"2010","unstructured":"Abu-Amara M, Yang SY, Tapuria N, Fuller B, Davidson B, Seifalian A. Liver Ischemia\/Reperfusion Injury: Processes in Inflammatory Networks-A Review. Liver Transpl. 2010;16(9):1016\u201332.","journal-title":"Liver Transpl"},{"issue":"2","key":"1447_CR37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI116223","volume":"91","author":"B Gonzalez-Flecha","year":"1993","unstructured":"Gonzalez-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest. 1993;91(2):456\u201364.","journal-title":"J Clin Invest"},{"issue":"2","key":"1447_CR38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2011.12.014","volume":"161","author":"BJ Crielaard","year":"2012","unstructured":"Crielaard BJ, Lammers T, Schiffelers RM, Storm G. Drug targeting systems for inflammatory disease: One for all, all for one. J Control Release. 2012;161(2):225\u201334.","journal-title":"J Control Release"},{"issue":"4","key":"1447_CR39","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/mp2000742","volume":"8","author":"JM Hoven van den","year":"2011","unstructured":"van den Hoven JM, Van Tomme SR, Metselaar JM, Nuijen B, Beijnen JH, Storm G. Liposomal Drug Formulations in the Treatment of Rheumatoid Arthritis. Mol Pharmaceutics. 2011;8(4):1002\u201315.","journal-title":"Mol Pharmaceutics"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-014-1447-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-014-1447-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T17:08:26Z","timestamp":1649696906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-014-1447-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,19]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1007\/s11095-014-1447-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,19]]}}}